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ABSTRACT	  
Controllable	  Inactivation	  of	  a	  Toxin-­‐based	  Tool	  to	  Target	  Actin	  in	  vivo	  
	  
Mathew	  A.	  Saab	  
2015	  
The	   actin	   crosslinking	   domain	   (ACD)	   is	   an	   effector	   domain	   of	   the	   larger	   MARTX	  
toxins	  produced	  by	  the	  Gram-­‐negative	  bacteria	  Aeromonas	  hydrophila,	  Vibrio	  cholerae,	  and	  
Vibrio	  vulnificus.	  ACD,	  an	  actin	  specific	  toxin,	  catalyzes	  the	  covalent	  crosslinking	  of	  actin	  via	  
formation	  of	  intermolecular	  isopeptide	  bonds	  between	  the	  K50	  and	  E270	  residues	  of	  actin	  
monomers.	   The	   resulting	   actin	   oligomers	   vary	   in	   size	   and	   are	   non-­‐polymerizable.	   It	   is	   a	  
widely	   accepted	   theory	   that	   ACD	   toxicity	   stems	   from	   direct	   disruption	   of	   the	   actin	  
cytoskeleton	   by	   depleting	   monomeric	   and	   filamentous	   actin	   pools,	   leading	   to	   the	  
accumulation	  of	  non-­‐polymerizable	  actin	  oligomers.	  Due	  to	  the	  high	  selectivity	  of	  ACD	  for	  
actin,	   this	   toxin	   is	   an	   attractive	   candidate	   for	   developing	   a	   tool	   to	   study	   actin	   in	   vivo.	  
However,	  a	  method	  to	  inactivate	  ACD	  inside	  the	  cell	  does	  not	  currently	  exist.	  	  
One	  potential	  solution	  is	  to	  use	  UV-­‐induced	  crosslinking	  proteins	  containing	  photo-­‐
sensitive	   amino	   acids.	   I	   hypothesize	   that	   substituting	   leucine	   residues	   in	   ACD	  with	   their	  
photo-­‐sensitive,	   artificial	   analog	   photo-­‐leucine	   (photo-­‐L)	   will	   allow	   for	   the	   recombinant	  
expression	  of	   functional	  ACD	  that	  can	  be	  inactivated	  upon	  UV	  light	  exposure.	  This	  will	  be	  
achieved	   by	   expressing	   ACD	   in	   the	   presence	   of	   photo-­‐L.	   Future	   steps	   are	   to	   utilize	   the	  
anthrax	  toxin	  translocation	  system	  (LFN	  domain	  and	  protective	  antigen)	  for	  delivery	  of	  the	  
photo-­‐controllable	  ACD	   to	   the	   cytoplasm	  of	   cultured	   cells	  where	   the	  ACD	  activity	   can	  be	  
controlled	  by	  simple	  exposure	  of	  the	  cells	  to	  light.	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Another	   potential	   solution	   is	   to	   modify	   ACD	   using	   a	   covalently	   bound	   photo-­‐
activatable	   crosslinker	   to	   produce	   ACD	   susceptible	   to	   UV-­‐induced	   crosslinking.	  
Benzophenone-­‐4-­‐maleimide	  (BPM)	  specifically	  and	  spontaneously	  attaches	  to	  thiol	  groups	  
characteristic	  of	  cysteine	  residues	  and	  is	  a	  good	  candidate	  crosslinker	  for	  such	  an	  approach.	  
Cys-­‐mutantions	  must	  be	   introduced	   into	  ACD	  because	   the	  wild-­‐type	  protein	   lacks	   sulfur-­‐
containing	  cysteine	  residues.	  To	  this	  end,	  ACD	  Cys-­‐mutants	  were	  generated	  via	  multisite-­‐
directed	   mutagenesis	   in	   order	   to	   produce	   a	   library	   of	   His-­‐tagged	   Cys-­‐mutant	   LFNACDVc	  
which	  were	  expressed	  in	  E.	  coli	  prior	  to	  being	  labeled	  with	  BPM.	  A	  convenient	  reporter	  for	  
the	  ACD	  toxin	  activity	  is	  covalent	  crosslinking	  of	  actin,	  which	  can	  be	  visualized	  using	  SDS-­‐
gel	   electrophoresis	   as	   an	   accumulation	   of	   higher	   molecular	   weight	   products	   of	   actin	  
crosslinking	  in	  the	  presence	  of	  active	  ACD.	  Preliminary	  results	  suggest	  that	  the	  introduced	  
Cys-­‐mutations	   affect	   the	   activity	   of	   ACD	   even	   in	   the	   absence	   of	   BPM-­‐labeling.	   However,	  
recent	  results	  reveal	  that	  newer	  sites	  targeted	  for	  Cys-­‐mutation	  in	  ACD	  did	  not	  abolish	  the	  
toxin’s	  activity. With	  this	  achieved,	  the	  method	  should	  become	  a	  tool	  to	  allow	  on-­‐demand	  
ACD	  inactivation	  to	  further	  understand	  its	  pathogenicity	  and	  to	  study	  actin	  functions	  in	  vivo.	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1. Introduction	  
	  
1.1	  	   Actin	  in	  the	  cell	  
	  
	   Actin	   is	   a	   highly	   conserved	   protein	   across	   many	   eukaryotic	   species.	   Found	   as	   a	  
major	  protein	  component	  in	  various	  cell	  types,	  actin	  itself	  retains	  one	  important	  function:	  
to	  polymerize	  into	  filaments.	  Actin	  can	  be	  found	  in	  the	  equilibrium	  between	  the	  two	  states	  
described	  as	  monomeric	  (G-­‐actin)	  and	  polymerized,	  filamentous	  (F-­‐actin).1	  Actin	  works	  in	  
conjunction	   with	   many	   other	   proteins	   such	   as	   actin-­‐related	   proteins	   and	   those	   of	   the	  
formin	  family	  to	  polymerize	  into	  filaments	  critical	  to	  the	  structure	  and	  function	  of	  the	  actin	  
cytoskeleton	   of	  which	   reconstruction	   is	   paramount	   for	   cell	  motility,	  morphogenesis,	   and	  
division.2	  
	   The	  dynamics	  of	   actin	   is	   to	  be	   in	  perpetual	   flux	  between	  both	  G-­‐actin	   and	  F-­‐actin	  
states	   in	   order	   to	  provide	   semi-­‐flexible	   filament	  polymerization	   and	  depolymerization	   in	  
areas	   of	   the	   cell	   necessary	   for	   providing	   scaffolding	   for	   microvilli,	   lamellipodia	   and	  
filopodia,	  tracks	  for	  intracellular	  transport,	  and	  providing	  the	  force	  necessary	  for	  motility	  
on	   both	   the	   microscopic	   and	   macroscopic	   level.1,2	   The	   actin	   cytoskeleton	   of	   any	   cell	   is	  
continually	  regulated	  and	  under	  scrutiny	  by	  countless	  other	  proteins,	  and	  when	  the	  actin	  
cytoskeleton	  is	  disrupted,	  cell	  death	  is	  almost	  certain.1,2	  
1.2	   ACD’s	  role	  in	  bacterial	  pathogenesis	  	  	  
The	  actin	  crosslinking	  domain	  (ACD)	  (Figure	  1)	  is	  an	  effector	  domain	  of	  the	  MARTX	  
and	   VgrG1	   toxins	   produced	   by	   the	   Gram-­‐negative	   bacteria	  Aeromonas	   hydrophila,	   Vibrio	  
cholerae,	   and	   Vibrio	   vulnificus.	   ACD	   is	   an	   important	   virulence	   factor	   of	   ACD-­‐producing	  
bacteria	   as	   it	   helps	   to	   evade	  host	   immune	   responses	   by	   disabling	  macrophages.	  ACD,	   an	  
actin-­‐specific	   toxin,	   catalyzes	   the	   covalent	   crosslinking	   of	   actin	   via	   formation	   of	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intermolecular	   amide	   bonds	   between	   the	   side	   chains	   of	   K50	   and	   E270	   residues	   of	   actin	  
monomers.	   The	   resulting	   actin	   oligomers	   vary	   in	   size	   and	   are	   non-­‐polymerizable.	  
According	  to	  the	  current	  paradigm,	  ACD	  toxicity	  stems	  from	  direct	  disruption	  of	  the	  actin	  
cytoskeleton	   by	   depleting	   monomeric	   and	   filamentous	   actin	   pools,	   leading	   to	   the	   bulk	  
accumulation	   of	   non-­‐polymerizable	   actin	   oligomers,	   cell	   rounding,	   and	   eventually	   cell	  
death.3,4	  	  
In	  contrast	  to	  the	  previously	  accepted	  view,	  the	  Kudryashov	  lab	  has	  found	  that	  only	  
small	   amounts	   of	   oligomers	  may	   in	   fact	   be	   very	   toxic	   to	   the	   cell.	   However,	   currently	   no	  
method	  for	  on-­‐demand	  inactivation	  of	  ACD	  exists;	  therefore	  no	  method	  for	  in	  vivo	  testing	  of	  
low	  concentrations	  of	  actin	  oligomers	  exists,	  and	  such	  a	  hypothesis	  remains	  unable	  to	  be	  
directly	   tested.	   This	   thesis	   is	   focused	   on	   exploring	   a	   method	   for	   developing	   photo-­‐
deactivatable	   ACD	   in	   order	   to	   gain	   spatiotemporal	   control	   over	   ACD’s	   activity.	   Two	  
approaches	   are	   investigated	   in	   this	   work:	   1)	   using	   photo-­‐sensitive	   amino	   acid,	   photo-­‐
leucine;	  2)	  employing	  photo-­‐activatable	  crosslinker,	  benzophenone-­‐4-­‐maleimide.	  
1.3	   Photo-­‐leucine	  as	  a	  crosslinker	  
L-­‐2-­‐amino-­‐4,4-­‐azi-­‐pentanoic	  acid,	  more	  commonly	  known	  as	  photo-­‐leucine	  (photo-­‐
L)	  (Figure	  6),	   	   is	  an	  artificial	   leucine	  analog	  that	  contains	  a	  diazirine	  ring	  in	  its	  side	  chain	  
capable	  of	  activation	  upon	  exposure	  to	  UV	  radiation	  to	  form	  a	  highly	  reactive	  intermediate	  
useful	  for	  crosslinking	  to	  the	  side	  chains	  of	  nearby	  amino	  acid	  residues.	  When	  eukaryotic	  
cells	   are	   grown	   in	   media	   containing	   photo-­‐L,	   this	   photo-­‐sensitive,	   artificial	   amino	   acid	  
analog	   has	   been	   demonstrated	   to	   incorporate	   into	   expressed	   proteins	   at	   sites	   normally	  
occupied	  by	  leucine	  residues.5	  However,	  use	  of	  photo-­‐L	  in	  a	  prokaryotic	  expression	  system	  
has	   never	   been	   reported.	   If	   successful,	   this	   method	   will	   allow	   for	   the	   recombinant	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expression	  of	   functional	  ACD	  that	  can	  be	   inactivated	   in	   the	  cells	  by	  crosslinking	  upon	  UV	  
radiation	  exposure.	  
1.4	   Benzophenone-­‐4-­‐maleimide	  as	  a	  crosslinker	  
	  
	   Benzophenone-­‐4-­‐maleimide	   (BPM)	   is	   a	   photo-­‐activatable	   crosslinker	   that	   can	   be	  
attached	  through	  thioether	  linkage	  specifically	  to	  sulfhydryl	  groups	  such	  as	  those	  found	  in	  
cysteine	  (Cys)	  residues	  via	  spontaneous	  thioether	   linkage	  under	  physiological	  conditions.	  
When	   illuminated	   with	   UV	   radiation,	   BPM	   produces	   an	   highly	   reactive,	   free	   radical	  
intermediate,	  which	  is	  susceptible	  to	  crosslinking	  with	  the	  side	  chains	  of	  nearby	  amino	  acid	  
residues.6	  Careful	  selection	  of	  the	  crosslinking	  sites	  on	  the	  toxin	  should	  preserve	  the	  ACD	  
activity	  upon	  BPM	   labeling	  but	   lead	   to	  protein	   inactivation	  upon	  crosslinking	   induced	  by	  
the	  UV	  irradiation.	  
1.5	   Thesis	  Overview	  
	   The	  ACD	  orthologs	  used	  in	  experiments	  described	  throughout	  this	  thesis	  are	  those	  
produced	  by	  Vibrio	  cholerae	   and	  Aeromonas	  hydrophila	  (and	   therefore,	  are	   referred	   to	  as	  
ACDVc	  and	  ACDAh,	  respectively).	  	  
In	   this	   work,	   I	   expressed	   LFNACDAh,	   a	   construct	   of	   ACD	   fused	   C-­‐terminally	   to	   the	  
300-­‐residue	  N-­‐terminal	   domain	   of	   lethal	   factor	   (LFN),	   a	  Bacillus	  anthracis	   toxin.	   LFN	   is	   a	  
benign	  part	  of	   the	   toxin	  capable	  of	  binding	   to	  B.	  anthracis	  protective	  antigen	  (PA),	  which	  
can	   be	   used	   for	   intracellular	   delivery	   of	   ACD.7	   Photo-­‐L-­‐containing	   toxin	   was	   expressed	  
using	   the	   pCold	   DNA	   Cold	   Shock	   Expression	   system	   (Clontech)8	   in	   minimal	   M9	   media	  
supplemented	  with	  photo-­‐L.	  The	  recombinant	  protein	  was	  exposed	  to	  UV	  radiation.	  Actin	  
crosslinking	  capabilities	  were	  compared	  to	  LFNACDAh	  unexposed	  to	  UV	  light	  by	  SDS-­‐PAGE.	  
Alternatively,	   LFNACDVc	   was	   subjected	   to	   multisite-­‐directed	   mutagenesis	   in	   order	   to	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produce	   toxin	   that	   contained	   Cys	   residues	   necessary	   for	   BPM	   labeling.	   After	   labeling,	  
mutant	  LFNACDVc	  was	  subjected	  to	  UV	  light	  and	  actin	  crosslinking	  was	  compared	  with	  that	  
in	   the	   absence	   of	   UV	   exposure,	   again	   by	   SDS-­‐PAGE.	   By	   developing	   a	   form	   of	   ACD	  
inactivatable	   upon	   UV	   irradiation,	   I	   expect	   to	   produce	   a	   tool	   that	   will	   allow	   for	   further	  
study	  of	  ACD’s	  toxicity.	  
	   In	   the	   following	   chapters,	   I	   will	   describe	   detailed	   methodology	   for	   the	   LFNACD	  
expression,	  mutagenesis,	  and	  actin	  crosslinking	  assays	  (used	  to	  assess	  ACD	  activity).	  I	  will	  
then	   explain	   the	   implication	   of	   my	   results	   and	   discuss	   some	   of	   my	   project’s	   challenges.	  
Finally,	   I	  will	  propose	  future	  actions	  to	  take	  for	  continuing	  this	  project,	  and	  I	  will	  discuss	  
the	  potential	  significance	  of	  this	  project	  and	  the	  importance	  of	  the	  study	  of	  ACD.	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2.	  Results	  
2.1	   ACD	   retains	   crosslinking	   activity	   following	   expression	   in	   M9	   media	  
supplemented	  with	  photo-­‐L	  
	  
As	  a	  first	  approach	  to	  achieve	  the	  main	  goal	  of	  producing	  photo-­‐inactivatable	  ACD,	  
LFNACDAh	   (64	   Leu	   residues)	  was	   expressed	   in	  E.	  coli	   BL21	   (DE3)	   pLysS	   using	  M9	   amino	  
acid	   drop-­‐off	   media	   supplemented	   with	   either	   leucine	   or	   photo-­‐L	   (Figure	   8).	   Actin	  
crosslinking	  is	  a	  convenient	  indicator	  for	  ACD	  activity,	  even	  in	  bacterial	  cell	  lysates	  without	  
protein	  purification.	  Small-­‐scale	  expression	  allows	  for	  processing	  simultaneously	  up	  to	  24	  
samples,	  allowint	  the	  rapid	  analysis	  of	  several	  conditions	  for	  protein	  expression	  at	  a	  time.	  
After	  small-­‐scale	  expression	  in	  the	  dark	  using	  the	  pCold	  DNA	  Cold	  Shock	  Expression	  system	  
(Clontech),	  bacterial	  cell	  lysate	  samples	  were	  exposed	  to	  365	  nm	  UV	  radiation	  at	  15	  cm	  for	  
30	  minutes.	   Those	   samples	   as	  well	   as	   those	   unexposed	  were	   added	   to	   actin	   for	   in	   vitro	  
crosslinking	   assays	   for	   analysis	   by	   SDS-­‐PAGE	   (Figure	   9).	   Actin	   oligomers	   formed	   in	   the	  
presence	   of	   ACD	   did	   not	   separate	   into	   monomers	   under	   the	   SDS-­‐conditions,	   and	   this	  
confirms	  the	  oligomers’	  covalent	  nature	  and	  suggests	  that	  the	  toxin	  remained	  active	  even	  
after	  treatment	  with	  UV	  light.	  	  
2.2	   In	  vitro	   actin	   crosslinking	   results	   are	   ambiguous	   as	   to	  whether	   photo-­‐L	  was	  
incorporated	  into	  protein	  expression	  
	  
	   Actin	   oligomers	   were	   observed	   to	   form	  with	   toxin	   expressed	   in	   high	   amounts	   of	  
photo-­‐L.	  Actin	  crosslinking	  capability	  was	  not	  diminished	  in	  samples	  treated	  with	  UV	  light.	  
Analysis	  of	  the	  cell	  lysates	  revealed	  that	  LFNACDAh	  was	  successfully	  expressed	  in	  both	  cells	  
cultured	  in	  media	  containing	  leucine	  as	  well	  as	  in	  media	  containing	  photo-­‐L.	  The	  toxin	  was	  
found	  in	  the	  lysate	  supernatants	  (Figures	  8,	  10).	  This	  suggested	  that	  the	  expressed	  protein	  
was	  capable	  of	  proper	  folding	  to	  be	  soluble	  in	  cell	  cytosol,	  which	  would	  be	  useful	  for	  future	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in	  vivo	   assays.	  UV-­‐treated	   lysate	  supernatants	  were	  visible	  on	   the	  gel,	   suggesting	   that	  UV	  
treatment	  did	  not	  induce	  protein	  degradation	  in	  expressed	  LFNACDAh.	  
	   Analysis	  of	   the	  SDS-­‐PAGE	  for	  respective	  actin	  crosslinking	  activity	  assays	  revealed	  
that	  expressed	  LFNACDAh	  retained	  activity,	  even	  when	  expressed	  in	  the	  presence	  of	  photo-­‐L	  
without	  natural	   leucine.	   Surprisingly,	   all	  UV-­‐treated	  LFNACDAh	   retained	  actin	   crosslinking	  
capability.	   This	   result	   indicates	   that	   despite	   successful	   protein	   expression	   under	   strict	  
conditions	  of	  luecine	  deficit,	  the	  cells	  may	  still	  have	  had	  managed	  to	  produce	  leucine	  from	  
catabolic	  products	  of	  glucose	  present	  in	  the	  media,	  which	  would	  suggest	  that	  photo-­‐L	  may	  
not	  have	  been	  incorporated.	  Therefore,	  we	  employed	  leucine	  and	  isoleucine	  auxotrophic	  E.	  
coli	   cells	   (ML2,	   a	   C43	   (DE3)-­‐based	   strain)	   for	   LFNACD	   expression.	   These	   cells	   were	  
considered	   Ile	   auxotrophs	   because	   they	   lacked	   the	   ilvE	   gene,	   which	   coded	   for	   a	  
transaminase	   necessary	   for	   the	   biosynthetic	   pathway	   employed	   to	   synthesize	   Ile.	  
Additionally,	   growth	   in	   media	   containing	   0.4-­‐1	   mM	   Tyr,	   suppressed	   the	   tyrB	   gene,	  
rendering	   them	  unable	   to	  synthesize	   leucine	  and	   therefore	  act	  as	  Leu	  auxotrophs.	  Use	  of	  
the	  ML2	  strain	  of	  E.	  coli	   in	  this	  study	  was	  done	  so	  in	  order	  to	  control	  leucine	  and	  photo-­‐L	  
incorporation	  during	  protein	  expression.9	  
	   SDS-­‐PAGE	   analysis	   of	   the	   LFNACD	  expressions	   from	   ML2	   cells	   revealed	   that	   cells	  
grown	   in	   the	   presence	   of	   photo-­‐L	   were	   not	   able	   to	   express	   LFNACDAh	   perhaps	   because	  
existing	   tRNA	   does	   not	   recognize	   photo-­‐L.	   Interestingly,	   cells	   grown	   without	   leucine	   or	  
photo-­‐L	   and	   only	   with	   isoleucine	   were	   able	   to	   express	   LFNACDAh.	   This	   suggests	   that	  
perhaps	   basal	   levels	   of	   protein	   degradation	   provided	   enough	   leucine	   for	   LFNACDAh	  
expression	   or	   that	   perhaps	   cells	   used	   were	   able	   to	   synthesize	   their	   own	   leucine	   from	  
glucose	  catabolites	   in	  the	  media	  and	  that	  methods	  used	  were	  therefore	  not	  optimized	  for	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the	  ML2	  cell	  line.	  Continued	  inability	  to	  produce	  a	  positive	  result	  lead	  to	  the	  exploration	  of	  
another	  approach,	  one	  that	  centered	  on	  the	  photo-­‐activatable	  crosslinker,	  BPM.	  
2.3	   ACD	  retains	   crosslinking	  activity	   following	  mutagenesis	  of	   select	   residues	   to	  
cysteine	  
	  
	   Since	   wild	   type	   ACD	   lacks	   any	   Cys	   residues,	   multisite-­‐directed	   mutagenesis	   was	  
performed	   on	   various	   sites	   to	   produce	   a	   library	   of	   His-­‐tagged	   Cys-­‐mutant	   LFNACDVc	   In	  
order	   to	   label	   with	   BPM.	   A	   “semi-­‐high-­‐throughput”	   screening	   method	   was	   employed	   in	  
which	  multisite-­‐directed	  mutagenesis	  yielded	  a	  plethora	  of	  mutant	  toxins	  carrying	  various	  
combinations	  of	  the	  mutations	  introduced	  using	  the	  designed	  primers.	  Under	  this	  method,	  
up	   to	   twenty-­‐four	  mutant	   toxins	   at	   once	  were	   able	   to	   be	   labeled	  with	  BPM,	   purified,	  UV	  
irradiated,	  and	  tested	  for	  actin	  crosslinking	  capabilities.	  Plasmids	  encoding	  toxin	  capable	  of	  
actin	   crosslinking	  were	   sequenced,	   allowing	   for	   the	   development	   of	   a	   library	   of	  mutants	  
with	  various	  actin	  crosslinking	  abilities.	  	  
Primers	   for	   the	   first	   round	   of	   LFNACDVc	  mutagenesis	  were	   designed	   so	   to	  mutate	  
residues	   in	   close	   proximity	   of	   the	   ACD	   active	   site.	   The	  mutant	   toxins	  were	   labeled	  with	  
BPM	  prior	   to	  being	   subjected	   to	  metal	   ion	  affinity	   chromatography	  using	   cobalt	   columns	  
and	   eluted	   with	   imidazole	   in	   order	   remove	   other	   proteins	   and	   excess	   BPM	   and	  
dithiothreitol	  followed	  by	  irradiation	  with	  302	  nm	  UV	  radiation.	  SDS-­‐PAGE	  analysis	  for	  all	  
mutants	   explored	   from	   the	   first	   round	   of	   LFNACDVc	  mutagenesis	   revealed	   no	   expression	  
concerns	   (Figure	   11).	   However,	   upon	   examination	   of	   SDS-­‐PAGE	   for	   subsequent	   actin	  
crosslinking	   activity	   assays	   of	   respective	   protein	   expressions,	   no	   mutant	   LFNACDVc	  
produced	  was	   able	   to	   retain	   activity	   after	   just	  UV	   exposure	   or	   just	   BPM	   labeling	   only	   to	  
have	   its	   activity	   abolished	   upon	   BPM	   labeling	   coupled	   with	   subsequent	   UV	   treatment	  	  
(Figure	  11).	  This	  is	  significant	  because	  mutants	  capable	  of	  doing	  so	  would	  be	  ones	  that	  are	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spatiotemporally	   controllable	   through	   photo-­‐inactivation	   and	  would	   be	   of	   interest	   for	   in	  
vivo	  studies	  mentioned	  in	  1.5.	  Mutants	  that	  presented	  no	  activity	  under	  any	  experimental	  
conditions	  were	   likely	  to	  have	  sites	  essential	   to	  protein	  function	  mutated	  to	  Cys.	  Mutants	  
that	   lost	   actin	   crosslinking	   capability	   following	   BPM	   labeling	  most	   likely	   did	   so	   because	  
BPM	  is	  a	  large,	  bulky	  compound	  that	  interfered	  with	  protein	  activity	  once	  attached	  to	  these	  
sites.	  Therefore,	   primers	  were	   redesigned	   to	   avoid	   such	   scenarios,	   and	  another	   round	  of	  
multisite-­‐directed	  mutagenesis	  was	  performed.	  
2.4	   Additional	  bulk	  from	  BPM	  does	  not	  interfere	  with	  ACD	  crosslinking	  activity	  at	  
select	  residues	  
	  
	   Considering	  that	  BPM	  is	  a	  sterically	  bulky	  molecule	  (Figure	  4),	  it	  could	  be	  expected	  
that	  its	  presence	  when	  attached	  to	  Cys	  residues	  near	  the	  active	  site	  may	  interfere	  with	  the	  
activity	  of	  the	  ACD	  toxin.	  Therefore,	  primers	  for	  the	  second	  round	  of	  LFNACDVc	  mutagenesis	  
were	   selected	   to	   introduce	   Cys	   residues	   using	   the	   crystal	   structure	   of	   VgrG1	  ACD	   (PDB:	  
4DTH,	  an	  ACDVc	  homolog)	  based	  on	  the	  following	  criteria:	  1)	  distant	  from	  the	  ATP-­‐binding	  
cleft,	  2)	  along	  the	  ACD/actin	  interface,	  3)	  do	  not	  participate	  in	  formation	  of	  alpha-­‐helix	  or	  
beta-­‐pleated	  sheet,	  and	  4)	  preferably	   tyrosine	  or	   tryptophan	   in	  order	   to	  mimic	   the	  bulky	  
ring	   structure	   of	   BPM.	   Several	   mutants	   generated	   upon	   second	   round	   of	   mutagenesis	  
retained	   actin	   crosslinking	   capability	   after	   BPM	   labeling	   as	   judged	   by	   the	   SDS-­‐PAGE	  
analysis	  (Figure	  13).	  This	  reinforces	  that	  additional	  bulk	  from	  BPM	  modification	  does	  not	  
interfere	  with	  ACD	  crosslinking	  activity	  at	  select	  residues.	  
2.5	   BPM	   labeling	   of	   LFNACDVc	   carrying	   Y357C	   and	   D448C	   mutations	   results	   in	  
inactivation	  of	  the	  toxin	  upon	  exposure	  to	  UV	  light	  
	  
	   In	   order	   to	   achieve	   the	  main	   goal,	   Cys-­‐mutants	   of	   ACD	  must	   retain	   their	   activity	  
under	  the	  conditions	  of	  UV	  exposure	  and	  BPM	  labeling	  (when	  performed	  exclusively	  from	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each	  other),	   but	  mutants	   lose	   activity	  when	  UV	   treatment	   follows	  BPM	   labeling.	  Mutants	  
capable	  of	  doing	  that	  could	  potentially	  be	  labeled	  with	  BPM	  and	  then	  delivered	  to	  a	  cell	  for	  
photo-­‐inactivatable	  in	  vivo	  actin	  crosslinking.	  All	  of	  the	  mutant	  toxins	  except	  one	  lost	  actin	  
crosslinking	  capability	  either	  after	  Cys	  replacement,	  labeling	  with	  BPM,	  or	  exposure	  to	  UV	  
light	  before	  BPM	   labeling.	  However,	   the	  one	  potentially	  promising	  candidate,	  mutant	   “6,”	  
retained	   its	   actin	   crosslinking	   activity	   after	   all	   of	   these	   conditions,	   but	   its	   activity	   was	  
abolished	   upon	   UV	   irradiation	   of	   the	   BPM	   form	   (Figure	   13).	   Mutant	   “6”	   plasmid	   was	  
sequenced	   to	   reveal	   that	   it	   contained	  Y357C	   and	  D448C	  mutations	   in	   the	  ACD	   sequence	  
(Figure	  14).	  This	  result	   implies	  that	  mutant	  “6”	   is	  a	  photo-­‐inactivatable	   form	  of	  ACD,	  and	  
that	  the	  main	  goal	  of	  this	  study	  has	  been	  met.	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3.	  Discussion	  
	   Actin	   filament	   assembly	   and	   disassembly	   as	   achieved	   through	   G-­‐actin/F-­‐actin	  
treadmilling	  is	  crucial	  to	  many	  functions	  of	  the	  cell	  including	  life	  of	  the	  cell	  itself.	  Therefore,	  
disruption	  of	  the	  actin	  cytoskeleton	  has	  a	  high	  potential	  to	  be	  detrimental.	  ACD-­‐mediated	  
crosslinking	  of	  G-­‐actin	  occurs	  via	   the	   formation	  of	   an	  amide	  bond	  between	   the	   lysine-­‐50	  
residue	   of	   one	   monomer	   and	   the	   glutamate-­‐270	   of	   another,	   resulting	   in	   covalently	  
crosslinked	   actin	   oligomers,	   which	   	   do	   not	   readily	   disassemble	   back	   into	   G-­‐actin.	  
Furthermore,	   because	   the	   oligomers	   may	   not	   participate	   in	   conventional	   actin	   filament	  
polymerization	  due	   to	   geometrical	   constraints,	   catalytic	   activity	   of	  ACD	   in	   the	   cell,	   if	   left	  
uninterrupted,	   depletes	   both	   the	   pool	   of	   G-­‐actin	   that	   is	   normally	   readily	   available	   for	   F-­‐
actin	   polymerization	   and	   the	   pool	   of	   F-­‐actin	   (due	   to	   actin	   treadmilling)	   by	   sequestering	  
eventually	   all	   actin	   into	  oligomeric	   form.	   Implications	  of	   this	   occurrence	   are	  observed	   in	  
cell	  rounding	  and	  detachment	  from	  substrate.	  However,	  to	  directly	  test	  our	  hypothesis	  that	  
extensive	   G-­‐actin	   pool	   depletion	   is	   not	   necessary	   for	   cell	   toxicity,	   a	   form	   of	   ACD	   that	   is	  
deactivatable	  on-­‐demand	  must	  be	  produced	  to	  be	  able	  to	  form	  controllable	  small	  amounts	  
of	  covalently	  crosslinked	  actin	  oligomers	  inside	  the	  cell.	  
	   In	  the	  development	  of	  methods	  outlined	  in	  this	  thesis,	  considerations	  needed	  to	  be	  
made	   for	   an	   approach	   that	  would	   offer	   swift,	   on-­‐demand,	   complete	   inactivation	   of	   ACD.	  
Existing	   methods	   of	   protein	   inactivation	   in	   a	   cellular	   context	   did	   not	   satisfy	   these	  
parameters.	  For	  example,	  degrons,	  peptide	  domains	  commonly	  found	  at	  the	  terminal	  ends	  
of	  proteins	  which	   they	  are	   linked,	  mark	   the	  protein	   for	  ubiquitination.10,11	  Degrons	  were	  
not	  implemented	  in	  this	  study	  because	  they	  rely	  on	  proteasomal	  degradation,	  which	  would	  
be	  slower	  than	  desired	  because	  it	  would	  not	  simultaneously	  target	  every	  molecule	  of	  ACD	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in	  the	  host	  cell.10,11	  Another	  approach	  using	  light,	  oxygen,	  voltage	  domains	  (LOV	  domains)	  
linked	  to	  ACD	  for	  photo-­‐inactivation	  via	  UV	  radiation	  would	  result	  in	  a	  protein	  susceptible	  
to	   reactivation	   after	   some	   time	   without	   UV	   irratiation.12–14	   However,	   a	   permanently	  
deactivated	  toxin	  was	  desired	  for	  this	  study.	  Additionally,	  since	  expression	  of	  the	  toxin	  in	  a	  
host	   would	   be	   highly	   toxic	   and	   uncontrollable,	   this	   study	   involved	   the	   expression	   of	  
LFNACD	   in	   a	   prokaryotic	   organism	   with	   the	   intention	   of	   future	   testing	   the	   toxin	   in	  
eukaryotic	  cells.	  Therefore,	  neither	  degrons	  nor	  LOV	  domains	  were	  implemented	  because	  
in	  order	  to	  be	  transported	  across	  the	  cell	  membrane	  using	  anthrax	  delivery	  machinery,	  all	  
components	  fused	  to	  LFN	  must	  be	  thermolabile	  and	  flexible.	  Fusion	  of	  pliable	  ACD	  with	  LFN	  
has	   already	   been	   demonstrated	   to	   cross	   the	  membrane	   and	   retain	   activity.3	   Fusing	   ACD	  
with	  folded	  domains	  such	  as	  degron	  or	  LOV	  would	  almost	  certainly	  affect	  the	  deliverability	  
of	   the	   toxin	   across	   membranes	   and	   negate	   the	   benefit	   of	   LFN	   fusion	   for	   future	   in	   vivo	  
studies.	  
	   Another	   existing	  method	   of	   altering	   protein	   activity,	   photo-­‐caging,	   is	   a	   process	   in	  
which	   UV	   light	   exposure	   activates	   the	   desired	   protein	   by	   catalyzing	   its	   removal	   from	   a	  
“caging	   group,”	  which	  when	   linked,	   functions	   to	   keep	   the	   protein	   inactive.15–18	  However,	  
this	  process	  is	  performed	  for	  permanent	  activation	  rather	  than	  inactivation	  of	  the	  desired	  
protein,	  so	  it	  was	  therefore	  not	  implemented	  in	  this	  study.	  	  
	   With	   that	   said,	   two	   approaches	   have	   been	   explored	   in	   order	   to	   develop	   photo-­‐
inactivatable	  ACD.	   First	   ,	   I	   explored	  expressing	   the	   toxin	   from	  media	   supplemented	  with	  
photo-­‐L.	  We	  hypothesize	  that	  ACD	  containing	  photo-­‐L	  in	  place	  of	  endogenous	  Leu	  residues	  
might	  be	  inactivated	  upon	  UV	  irradiation.	  In	  this	  mechanism,	  photo-­‐L	  diazirine	  rings	  would	  
be	  activated	  to	  release	  N2	  and	  form	  a	  reactive	  carbine	  intermediate	  species	  susceptible	  to	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intramolecular	  crosslinking.	  The	  latter	  would	  alter	  the	  protein’s	  structure,	  thus	  rendering	  it	  
inactive.	  Use	  of	  photo-­‐L	   for	   the	   expression	  of	   crosslinkable	  proteins	   is	   relatively	  popular	  
albeit	  when	  the	  expression	  is	  being	  performed	  in	  eukaryotic	  organisms.5	  However,	  photo-­‐L	  
has	   never	   been	   shown	   to	   be	   incorporated	   into	   protein	   expressed	   from	   a	   prokaryotic	  
organism.	  The	  alternative	  approach	  outlined	   in	   this	   thesis	   centered	  around	  using	  BPM,	  a	  
photo-­‐activatable	  crosslinker,	  to	  label	  the	  toxin	  to	  turn	  it	   into	  a	  controllable	  tool	  for	  actin	  
crosslinking.	  Unlike	  degrons,	  both	  of	  these	  approaches	  aim	  to	  render	  efficient	  control	  of	  the	  
toxin	  as	  inactivation	  is	  to	  be	  achieved	  through	  UV	  exposure.	  
	   The	  work	  performed	  in	  this	  thesis	  was	  conducted	  to	  support	  of	  another	  study	  that	  
intends	   to	   discover	  whether	   low	  ACD-­‐mediated	   actin	   oligomers	  may	   themselves	   be	   very	  
toxic	   to	   the	   cell.	   The	   Y357C/D448C	   ACD	   mutant	   produced	   through	   this	   thesis’s	  
experiments	   appears	   to	   be	   a	   photo-­‐inactivatable	   form	   of	   ACD	   and	   thus	   a	   promising	  
candidate	   for	   use	   in	   testing	   the	   adjacent	   study’s	   hypothesis.	   Future	   investigation	   of	   the	  
mutant	  in	  vivo	  is	  to	  be	  performed.	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4.	  Materials	  and	  Methods	  
	   This	  chapter	  describes	  the	  experimental	  protocols	  employed	  to	  execute	  the	  research	  
approaches	  discussed	  throughout	  the	  previous	  chapters.	  The	   first	  subchapter	  will	  outline	  
those	  used	   in	   the	  approach	  of	  producing	  LFNACDAh	   constructs	  using	  photo-­‐L.	  The	   second	  
subchapter	   will	   outline	   those	   used	   to	   produce	   LFNACDVc	   mutants	   subjectable	   to	   BPM	  
labeling.	  
4.1	   Photo-­‐L	  Protocol	  (Figure	  5)	  
4.1.1	   Expression	  of	  LFNACDAh	  in	  presence	  of	  photo-­‐L	  
	   pCold	   (Clontech)	   DNA	   plasmid	   encoding	   LFNACDAh	   was	   transformed	   into	   either	  
BL21	   (DE3)	   pLysS	   or	  ML2	   (a	   C43	  DE3-­‐based	   Leu-­‐auxotrophic	   strain)	   competent	   cells.	   A	  
single	  colony	  from	  the	  transformation	  was	  used	  to	  grow	  a	  culture	  of	  cells	  for	  16	  hours	  at	  
37	   °C,	   shaking	   at	   250	   rpm.	   The	   culture	   was	   used	   to	   inoculate	   into	   25	   mL	   of	   MMI	   rich	  
medium	  (tryptone	  1.25%,	  yeast	  extract	  2.50%,	  NaCl	  1.25	  mM,	  glycerol	  0.40%,	  Tris-­‐HCl	  50	  
mM	  at	  pH	  8.2)	  and	  cells	  were	  grown	  at	  37	  °C,	  shaking	  at	  250	  rpm	  until	  their	  optical	  density	  
at	  600nm	  was	  between	  1.2	  and	  1.8	  as	  determined	  using	  a	  spectrophotometer.	  Cells	  were	  
washed	  with	  M9	  salts	  (0.11M	  KH2PO4,	  0.266M	  Na2HPO4x2H2O,	  0.043M	  NaCl,	  pH	  7.2)	  before	  
being	  resuspended	  in	  M9-­‐amino	  acid	  drop	  off	  media	  (5X	  M9	  salts	  1:5,	  100X	  BME	  Vitamins	  
1:100	  (Sigma	  Aldrich),	  MgSO4	  2mM,	  CaCl2	  0.1mM,	  20%	  D-­‐glucose	  1:50,	  10%	  NH4Cl	  1:100)	  
and	  transferred	  to	  tubes	  wrapped	  in	  aluminum	  foil	  in	  2	  mL	  aliqots.	  Then,	  culture	  samples	  
were	   supplemented	   with	   leucine	   and	   Photo-­‐L	   according	   to	   (Figures	   8,	   10).	   Cells	   were	  
incubated	   at	   15	   °C,	   250	   rpm	   for	   three	   hours	   before	   the	   induction	   of	   the	   recombinant	  
protein	  expression	  with	  1mM	  IPTG	  followed	  by	  16	  hours	  of	   incubation	  at	  15	  °C,	  250	  rpm	  
(according	  to	  the	  Clontech	  manual	  for	  pCold	  DNA	  Cold	  Shock	  Protein	  Expression	  system).8	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Cells	  were	   resuspended	   in	   lysis	  buffer	   (Tris-­‐HCl	  20mM	  at	  pH=8,	  NaCl	  500mM,	   imidazole	  
10mM,	  MgCl2	  2mM,	  PMSF	  0.5mM,	  Leupeptin	  1:500,	   trypsin	   inhibitor	  1:500,	  benzamidine	  
4mM)	  and	  lysed	  by	  freeze	  thawing	  (three	  cycles)	  with	  subsequent	  sonication	  (15x	  1	  second	  
pulses	  at	  60%	  amplitude).	  The	   lysates	  were	   fractionated	  by	  centrifugation	  (20,000	  xg	   for	  
20	  min	  at	  4	  °C	  ).	  Pellet	   (insoluble)	  and	  supernatant	   (soluble)	   fractions	  were	  analyzed	  via	  
SDS-­‐PAGE	   (Figures	   8,	   10).	   Samples	   of	   lysate	   supernatants	   were	   subjected	   to	   365nm	  UV	  
light	  at	  15cm	  for	  30	  min	  on	  ice.	  
4.1.2	   Actin	  Crosslinking	  Activity	  Testing	  
A	  master	  mix	   for	   the	   reaction	   of	   ACD-­‐mediated	   actin	   crosslinking	  was	   assembled	  
(PMSF	  0.1mM,	  EGTA	  0.3	  mM,	  MgCl2	  0.1mM,	  ATP	  200	  μM,	  HEPES	  50mM	  at	  pH	  7.5,	  actin	  5	  
μM,	   latrunculin	   B	   6	   μM,	   cell	   lysate	   at	   the	   ratio	   of	   1:25	   to	   actin)	   and	   the	   reaction	   was	  
initiated	  by	  addition	  of	  MgCl2	  (1:10	  to	  achieve	  2	  mM	  final).	  Time	  point	  aliquots	  were	  taken	  
at	   0	  min,	   2	  min,	   and	   15	  min	   by	  mixing	   10	   μL	   of	   reaction	   solution	  with	   10	   μL	   of	   2X	   SDS	  
sample	  buffer.	  All	  samples	  were	  boiled	  for	  5	  min	  and	  analyzed	  by	  SDS-­‐PAGE	  (Figure	  9).	  
4.2	   BPM	  Protocol	  (Figure	  7)	  
4.2.1	   Multisite-­‐directed	  mutagenesis	  of	  LFNACDVc	  
Primers	  were	  developed	  using	  http://www.bioinformatics.org/primerx/	  that	  were	  
at	  least	  25	  bases	  long,	  had	  a	  GC-­‐content	  of	  at	  least	  40%,	  and	  had	  melting	  points	  between	  78	  
and	  80	  °C	  (Figures	  2,	  3).	  Primers	  were	  used	  simultaneously	  in	  the	  Lightning	  Quik-­‐Change	  
protocol	   for	   multi	   site-­‐directed	   mutagenesis	   (Agilent	   Technologies)	   to	   produce	   mutant	  
LFNACDVc	  plasmids.19	  
4.2.2	   Expression	  of	  LFNACDVc	  mutants	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Mutant	  LFNACDVc	  plasmids	  were	   transformed	   into	  BL21	   (DE3)	  pLysS	  cells.	  Replica	  
plates	   for	   future	  plasmid	  sequencing	  were	  created	   for	   the	  resulting	  colonies	  before	  using	  
the	  colonies	  for	  protein	  expression.	  Resulting	  colonies	  were	  used	  to	  inoculate	  into	  5	  mL	  of	  
MMI	   rich	  medium	   	  and	  cells	  were	  grown	  at	  37	   °C,	   shaking	  at	  250	  rpm	  until	   their	  optical	  
density	  at	  600	  nm	  was	  between	  1.2	  and	  1.8	  as	  determined	  using	  a	  spectrophotometer.	  The	  
induction	  of	  the	  recombinant	  protein	  expression	  was	  initiated	  with	  1mM	  IPTG	  followed	  by	  
16	  hours	  of	  incubation	  at	  15	  °C,	  250	  rpm	  (according	  to	  the	  Clontech	  manual	  for	  pCold	  DNA	  
Cold	  Shock	  Protein	  Expression	  system).	  Cells	  were	  resuspended	  in	  lysis	  buffer	  (Tris-­‐HCl	  20	  
mM,	  pH	  8,	  NaCl	  500	  mM,	  imidazole	  10	  mM,	  MgCl2	  2	  mM,	  PMSF	  0.5	  mM,	  Leupeptin	  1:500,	  
trypsin	   inhibitor	   1:500,	   benzamidine	   4	  mM)	   and	   lysed	   by	   freeze	   thawing	   (three	   cycles)	  
with	  subsequent	  sonication	  (15x	  1	  second	  pulses	  at	  60%	  amplitude).	  
4.2.3	   BPM	  labeling	  
Lysate	  samples	  were	  labeled	  with	  BPM	  (0.4	  mM	  final)	  in	  dimethylformamide,	  (DMF)	  
and	  left	  to	  interact	  on	  ice	  for	  one	  hour	  before	  being	  treated	  with	  dithiothreitol	  (DTT,	  4	  mM	  
final)	  to	  stop	  the	  labeling	  reaction.	  
4.2.4	   Protein	  purification	  
After	  BPM	  labeling,	  cell	  lysates	  were	  subjected	  to	  metal	  ion	  affinity	  chromatography	  
by	  loading	  onto	  Co2+	  columns.	  Columns	  were	  washed	  with	  lysis	  buffer	  until	  washes	  yielded	  
no	  protein	  as	   judged	  using	  Bradford	  Reagent	   (Bio-­‐Rad).	   Isolated	  protein	  was	   then	  eluted	  
using	  lysis	  buffer	  containing	  250	  mM	  imidazole.	  	  
4.2.5	   Actin	  crosslinking	  activity	  testing	  
Purified	  protein	  samples	  from	  section	  4.2.4.	  were	  subjected	  to	  302	  nm	  UV	  light	  for	  
15	   min	   on	   ice.	   A	   master	   mix	   for	   the	   reaction	   of	   ACD-­‐mediated	   actin	   crosslinking	   was	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assembled	  (PMSF	  0.1	  mM,	  EGTA	  0.3	  mM,	  MgCl2	  0.1	  mM,	  ATP	  200	  μM,	  HEPES	  50	  mM,	  pH7.5,	  
actin	   5	   μM,	   latrunculin	   B	   6	   μM,	   cell	   lysate	   1:25)	   and	   the	   reaction	   was	   initiated	   by	   the	  
addition	  of	  MgCl2	  (1:10	  to	  achieve	  2	  mM	  final).	  Aliquots	  10	  μL	  were	  withdrawn	  at	  15	  min	  
and	   mixed	   with	   10	   μL	   of	   2X	   SDS	   sample	   buffer.	   Results	   were	   analyzed	   by	   SDS-­‐PAGE	  
(Figures	  11,	  13).	  
	   	  





Figure	   1:	   The	   actin	   crosslinking	   domain	   (ACD)	   covalently	   crosslinks	   G-­‐actin	   via	  
catalysis	   of	   isopeptide	   bond	   formation	   between	   E270	   of	   one	   actin	   monomer	   and	  
K50	  of	  another,	  resulting	  in	  non-­‐polymerizable	  actin	  oligomers.	  This	  depletes	  both	  
the	  pool	  of	  G-­‐	  and	  F-­‐actin	  in	  the	  cell,	  disrupting	  functional	  and	  structural	  integrity	  of	  
the	  actin	  cytoskeleton	  and	  negating	  motile	  abilities.	  Adapted	  from	  Kudryashov	  et	  al.,	  
PNAS,	  2008.	  Copyright	  (2008)	  National	  Academy	  of	  Sciences.4	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Figure	  2:	  The	  crystal	  structure	  of	  VgrG1	  ACD	  generated	  using	  pyMol.	  The	  yellow	  molecule	  
is	  ATP.	  ACD	  is	  green,	  and	  residues	  targeted	  for	  round	  one	  mutagenesis	  are	  highlighted	  in	  
red.	  The	  group	  of	  mutations	  chosen	  in	  this	  round	  were	  meant	  to	  include	  both	  sites	  near	  and	  
































Figure	  3:	  The	  crystal	  structure	  of	  VgrG1	  ACD	  generated	  using	  pyMol.	  The	  yellow	  molecule	  
is	  ATP.	  ACD	  is	  green,	  and	  residues	  targeted	  for	  round	  two	  mutagenesis	  are	  highlighted	  in	  
red.	  The	  group	  of	  mutations	  chosen	  in	  this	  round	  were	  done	  so	  by	  the	  criteria	  outlined	  in	  
2.4.	  














Figure	   4:	   Benzophenone-­‐4-­‐maleimide’s	   (BPM)	   crosslinking	   mechanism:	   BPM	  
spontaneously	   links	   to	   sulfhydryl	   (thiol)	   groups	   to	   form	   stable	   thioethers.	   UV	   light	  
catalyzes	   formation	   of	   a	   highly	   reactive	   radical	   carbene	   at	   the	   ketone	   alpha	   carbon	  
susceptible	   for	   non-­‐specific	   linking	   elsewhere	   within	   the	   protein.	   Cys	   residues	   were	  
mutated	  into	  LFNACDVc	  to	  provide	  thiol	  groups	  for	  BPM	  attachment	  in	  this	  study.	  Adapted	  
from	  Hermanson,	  2013.	  Copyright	  (2013)	  Elsevier.6	  
	   	  






Figure	  5:	  Scheme	  of	  the	  protocol	  for	  the	  photo-­‐inactivation	  of	  ACD	  using	  LFNACD	  expressed	  




Figure	  6:	  Comparison	  of	  photo-­‐L	  (structure	  on	  left)	  and	  leucine	  (structure	  on	  right).	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Figure	  7:	  Scheme	  of	  the	  protocol	  for	  the	  photo-­‐inactivation	  of	  ACD	  using	  LFNACDVc	  mutants	  
labeled	  with	  BPM	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Figure	  8:	  SDS-­‐PAGE	  results	  for	  LFNACDAh	  expression	  in	  the	  presence	  of	  photo-­‐L.	  Expressed	  
protein	  can	  be	  located	  in	  both	  soluble	  (supernatant)	  and	  insoluble	  (pellet)	  portions	  of	  the	  
cell	  lysate.	  UV	  irradiation	  does	  not	  appear	  to	  degrade	  the	  protein.	  Media	  concentrations	  of	  
leucine	  and	  photo-­‐L	  for	  each	  condition	  are	  designated	  in	  the	  accompanying	  table.	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Figure	  9:	  SDS-­‐PAGE	  results	  for	  expressed	  LFNACDAh;	  results	  for	  protein	  samples	  exposed	  to	  
UV	  irradiation	  are	  depicted	  in	  the	  lower	  gel.	  Presence	  of	  oligomers	  in	  the	  lower	  gel	  suggests	  
UV	  light	  does	  not	  appear	  to	  demolish	  ACD’s	  actin	  crosslinking	  capability.	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Figure	  10:	  SDS-­‐PAGE	  results	  for	  LFNACDAh	  expression	  in	  the	  presence	  of	  photo-­‐L.	  Toxin	  
appears	  not	  to	  have	  expressed	  when	  in	  the	  presence	  of	  photo-­‐L,	  and	  it	  cannot	  be	  found	  in	  
the	  insoluble	  portion	  of	  cell	  lysate.	  Media	  concentrations	  of	  leucine	  and	  photo-­‐L	  for	  each	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Figure	  11:	  SDS-­‐PAGE	  results	  for	  first-­‐round	  	  LFNACDVc	  mutants’	  actin	  crosslinking	  
activity	  assays.	  None	  of	  the	  mutants	  1,	  2,	  3,	  or	  4	  displayed	  retention	  of	  activity	  post-­‐BPM	  
labeling	  and	  the	  complete	  loss	  of	  activity	  following	  subsequent	  UV	  treatment.	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Mutants	  
Mutations	   1	   2	   3	  
T312C	   YES	   YES	   NO	  
T349C	   YES	   YES	   NO	  
N550C	   YES	   YES	   YES	  
I621C	   YES	   /	   /	  
YES	  =	  mutation	  present	  
NO	  =	  mutation	  not	  present	  
/=	  Uncertainty	  due	  to	  sequencing	  errors	  
Figure	  12:	  Table	  outlining	  Cys	  mutations	  identified	  following	  first-­‐round	  	  of	  LFNACDVc	  
mutagenesis	  
	   	  
	   34 
	  
	  	   	  
Figure	   13:	   SDS-­‐PAGE	   results	   for	   second-­‐round	   LFNACDVc	   mutants’	   actin	   crosslinking	  
activity	   assays.	   A	   positive	   candidate,	  mutant	   “6”,	   displays	   retention	   of	   activity	   post-­‐BPM	  
labeling	  and	  the	  complete	  loss	  of	  activity	  following	  subsequent	  UV	  treatment.	  The	  mutant	  
“6”	  plasmid	  was	  sequenced	  to	  reveal	  Y357C	  and	  D448C	  mutations	  in	  the	  ACD	  sequence.	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